Bulletin
Investor Alert

Topics

Flu

Video

WSJ Opinion: The Making of an Asian-American Hate Narrative

  • WSJ Opinion: The Making of an Asian-American Hate Narrative WSJ Opinion: The Making of an Asian-American Hate Narrative 4:25
    WSJ Opinion: Joe Biden's Super State WSJ Opinion: Joe Biden's Super State 5:42
    WSJ Opinion: How the U.S. Fast-Tracked Covid Vaccines WSJ Opinion: How the U.S. Fast-Tracked Covid Vaccines 8:16
    Hospitals in Dakotas Prep for Post-Thanksgiving Jump in Covid Patients Hospitals in Dakotas Prep for Post-Thanksgiving Jump in Covid Patients 4:23
7:43 a.m. Today - By Quentin Fottrell
Weary of #fakenews, more Americans are getting their COVID-related news from peer-reviewed medical journals Social media doesn’t help people differentiate what is real from what is fake, but this class of publications mightSocial media doesn’t help people differentiate what is real from what is fake, but this class of publications might.
9:35 a.m. April 5, 2021 - By Tomi Kilgore
Chembio Diagnostics stock rockets on record volume after commercial launch of rapid COVID-19 testShares of Chembio Diagnostics Inc. skyrocketed 63.8% on record volume in afternoon trading Monday, to pace all gainers listed on major U.S. exchanges, in the wake of the point-of-care diagnostics company's announcement of the commercial launch of its rapid COVID-19/flu test. The stock was on track for the biggest one-day percentage gain since it doubled, on March 12, 2004. Trading volume ballooned to 206.6 million shares, compared with the full-day average of less than 1 million shares. The company said its test has been granted emergency use authorization by the Food and Drug Administration. Chembio said after Thursday's closing bell that the product, which produces results in 15 minutes, requires no instrumentation and simultaneously differentiates SARS-CoV-2 antigens and influenza Type A and Type B infections, is immediately available for shipment. "As COVID-19 converges with the flu, it is critical for physicians to be able to quickly differentiate between these viruses at the point-of-care, which present with nearly identical symptoms, in order to take appropriate clinical actions and maximize efficient use of healthcare resources," said Charles Caso, vice president of sales and marketing at Chembio. The stock has run up 21.4% year to date, while the S&P 500 has gained 8.6%.
1:38 p.m. April 3, 2021 - By MarketWatch
These money and investing tips can put a spring in your investing stepsMoney and investing stories popular with MarketWatch readers over the past week.
5:34 a.m. April 3, 2021 - By Quentin Fottrell
‘Frugality will continue to reign’: Eager to save hundreds of dollars, Americans flock to one type of product A new report from the Conference Board tracks three distinct trendsA new report from the Conference Board tracks three distinct trends.
3:26 a.m. March 31, 2021 - By Tonya Garcia
Walgreens sales miss expectations after weak cold and flu seasonWalgreens Boots Alliance Inc. reported fiscal second-quarter net income of $1.03 billion, or $1.19 per share, up from $946.0 million, or $1.07 per share last year. Adjusted EPS of $1.40 beat the FactSet consensus for $1.10 per share. Sales of $32.78 billion were up from $31.34 billion last year but below the FactSet consensus for $36.59 billion. Walgreens total excludes sales from discontinued operations of $4.8 billion. Comparable sales in the U.S. fell 3.5% due to a weak cough, cold and flu season. Comp sales for Boots UK fell 17.9% as COVID-19 restrictions reduced foot traffic on major high streets and transportation hubs. "Overall, we have achieved a good financial quarter with results well ahead of expectations, despite significant impacts from COVID-19, and we have raised our full-year EPS guidance," said Walgreens' new Chief Executive Roz Brewer in a statement. The former Starbucks Corp. executive assumed the role on . "I am optimistic about our ability to drive sustainable, long-term value for our shareholders, while acknowledging that there is still work to be done to stabilize the base business." Walgreens raised its fiscal 2021 adjusted EPS guidance to mid-to-high single digit growth in constant currency from low single-digit growth. The pharmacy retailer also expects the $6.5 billion divestiture of to be complete before the end of the fiscal year. Walgreens says it has administered eight million COVID-19 vaccinations and conducted five million COVID-19 tests. Walgreens stock rose 2.6% in Wednesday premarket trading and have gained 15.8% over the past year. The S&P 500 index is up 53.2% for the last 12 months.
3:24 a.m. March 30, 2021 - By Jaimy Lee
BD gets FDA authorization for test that can detect COVID-19 and the fluBecton, Dickinson & Co. said it received emergency authorization from the Food and Drug Administration for a rapid, antigen test that can detect SARS-CoV-2 and two types of influenza. The test, which runs on the company's BD Veritor System, takes about 15 minutes to produce results and is expected to be available this summer. BD's stock has gained 10.9% over the past 12 months, while the broader S&P 500 is up 56.2%.
1:23 p.m. March 25, 2021 - By Andrew Keshner
Real-estate agents are rethinking decades of advice on pools and how COVID-19 rewrote American shopping lists Thursday’s Personal Finance Stories Thursday’s Personal Finance StoriesThursday’s Personal Finance Stories.
12:19 p.m. March 24, 2021 - By Claudia Assis
Rite Aid stock down 18% after lower 2021 guidance on 'soft' flu seasonShares of Rite Aid Corp. fell more than 18% in the extended session Wednesday after the drugstore chain lowered its guidance for fiscal 2021, saying its bottom line was "significantly" hampered by a "soft" cold and flu season, the ongoing pandemic, and "challenging" weather. Same-store sales fell about 5.6% in the quarter ended in February, mostly due to a decline of nearly 37% percent in cough, cold and flu-related categories, the company said. Rite Aid also said it had administered about 1 million COVID-19 vaccines in March to date. The company said it expects fiscal 2021 revenue of about $24 billion, with same-store sales expected to increase about 3.5% compared with fiscal 2020. It called for a net loss between $90 million and $100 million for the year, and an adjusted EBITDA between $425 million and $435 million. Liquidity is about $1.7 billion, it said. Rite Aid is scheduled to report fourth-quarter results on April 15. The stock ended the regular trading day down 2.4%.
8:00 a.m. March 23, 2021 - By MarketWatch
A revolutionary ‘gray army’ of older workers is fighting our youth-obsessed culture — and we’ll all benefit if they winThe war against ageism will create career opportunities and a better work-life balance.
5:00 a.m. March 23, 2021 - By MarketWatch
Here are 5 post-pandemic moves investors should make now, says Wells FargoOur call of the day offers a few road maps to guide your investments out of the COVID-19 pandemic. Five things to do now.
5:01 a.m. March 10, 2021 - By Tonya Garcia
CVS locations in Target stores will begin administering COVID-19 vaccinationsTarget Corp. announced Wednesday that with CVS Health Corp. locations will administer COVID-19 vaccinations. Target and CVS have already partnered for flu, shingles and pneumonia vaccinations. The retailer will also make fitting rooms available for appointments. Target provides in order for employees to be vaccinated. Target stock has gained 65.4% over the past year while the S&P 500 index is up 34.5% for the period.
8:00 a.m. March 4, 2021 - By MarketWatch
Buy this dip in Apple, Microsoft and these other tech stocks before they’re out of reach, says analystIt’s been a bad week for tech stocks. The Nasdaq tumbled 2.7% on Wednesday and the slide looks set to continue on Thursday. So buy the dip before tech stocks move at least 25% higher this year, says veteran tech analyst Daniel Ives of investment firm Wedbush.
5:00 a.m. March 4, 2021 - By MarketWatch
Buy this dip in Apple, Microsoft and these other tech stocks before they’re out of reach, says analystIt’s been a bad week for tech stocks. The Nasdaq tumbled 2.7% on Wednesday and the slide looks set to continue on Thursday. So buy the dip before tech stocks move at least 25% higher this year, says veteran tech analyst Daniel Ives of investment firm Wedbush.
5:00 a.m. March 3, 2021 - By MarketWatch
Here’s the problem the Fed is fueling — and it’s not inflation, strategist saysOne strategist says the Fed's determination to keep interest rates low through quantitative easing is fueling another problem — it's limiting bank lending.
7:16 a.m. March 1, 2021 - By Alicia H. Munnell
Has COVID-19 really affected life expectancy? Many died in 2020-2021, but hopefully it is a one-shot event Many died in 2020-2021, but hopefully it is a one-shot event
5:00 a.m. March 1, 2021 - By MarketWatch
Bitcoin is at a ‘tipping point’ between mainstream boom and speculative implosion. Citi says one is more likelyCiti analysts said we could see a "massive transformation" of cryptocurrency into the mainstream.
4:10 a.m. Feb. 17, 2021 - By Jaimy Lee
Vir, GSK ink new R&D deal Shares of Vir Biotechnology Inc. were up 12.8% in premarket trading on Wednesday after the company said it would expand its research agreement with GlaxoSmithKline to include the flu and other respiratory diseases. As part of the deal, GSK will pay Vir $225 million upfront and will make an equity investment of $120 million in the biotech; it also has the option to develop one drug for $300 million, with the possibility of an additional $200 million in milestone payments. The companies had initially engaged in a deal in 2020 that is focused on studying treatments for coronaviruses, including SARS-CoV-2. One experimental COVID-19 treatment that the companies are already developing is VIR-7831, which is being tested in Phase 3 studies as a monotherapy and in a mid-stage trial as a combination therapy. Vir's stock has soared 287.7% over the past 12 months, while the broader S&P 500 is up 16.%.
5:00 a.m. Feb. 10, 2021 - By MarketWatch
Stocks aren’t in a bubble, but here’s what is, according to fund manager Cathie WoodThe manager of the ARK Innovation ETF points the bubble accusation at another asset class.
9:00 a.m. Feb. 1, 2021 - By Jaimy Lee
U.S. to pay testing company $231 million to speed up production of at-home COVID-19 testsThe Department of Defense awarded $231 million to Ellume, a privately held Australian diagnostic testing company that for its at-home COVID-19 test. The funding is expected to help increase the number of tests that the company can manufacture in the U.S., with a goal of producing 640,000 tests per day by the end of this year. As part of the agreement, the U.S. government also plans to purchase 8.5 million tests from Ellume. The test can be bought over-the-counter, similar to some cold-and-flu and allergy medicines. It costs $30.
7:26 a.m. Jan. 27, 2021 - By Quentin Fottrell
CDC Director: ‘I can’t tell you how much vaccine we have and, if I can’t tell it to you, then I can’t tell it to the governors’ President Joe Biden has outlined a goal of 100 million vaccinations in 100 days, which some analysts describe as ambitiousPresident Joe Biden has outlined a goal of 100 million vaccinations in 100 days, which some analysts describe as ambitious.
8:16 a.m. Jan. 24, 2021 - By Quentin Fottrell
Why do I need to wear a mask if I’ve had COVID-19? Who is it protecting? Can I really be reinfected? ‘Like everyone else, I am hoping that the vaccine will help infection rates and more people can get back to work’‘Like everyone else, I am hoping that the vaccine will help infection rates, and more people can get back to work.’
5:39 a.m. Jan. 17, 2021 - By Quentin Fottrell
Biden’s $1.9-trillion COVID-19 rescue plan is a ‘lifeline’ for millions of Americans President-elect Joe Biden said he will call for $1,400 stimulus checks and more vaccine funds in a new coronavirus economic relief package when he takes office this monthPresident-elect Biden said he will call for $1,400 stimulus checks and more vaccine funds in a new coronavirus economic relief package when he takes office this month.
5:16 a.m. Jan. 16, 2021 - By Quentin Fottrell
I didn’t receive a $1,200 stimulus check during the first surge of COVID-19. Will I get a payment this time around? President-elect Bidens said Thursday he will call for $1,400 stimulus checks and more vaccine funds in $1.9-trillion COVID-19 relief plan. President-elect Bidens said Thursday he will call for $1,400 stimulus checks and more vaccine funds in $1.9-trillion COVID-19 relief plan.
11:02 a.m. Jan. 15, 2021 - By Ciara Linnane
Global deaths from COVID-19 top 2 million as U.S. suffers most weekly fatalities since start of the pandemic Weekly deaths exceed CDC’s estimate for flu-related deaths for entire 2019-2020 season The global case tally for the coronavirus-borne illness COVID-19 climbed above 93 million on Friday and the death toll climbed above 2 million, with the U.S. leading all nations by cases and fatalities.
10:21 a.m. Jan. 13, 2021 - By Ciara Linnane
U.S. sees record one-day death toll and experts worry new variant may make activities like plane travel more risky Vaccine program must speed up to avoid reaching 640,000 deaths by spring, equal to lives lost in the 1918 flu pandemicThe U.S. set another grim milestone in the coronavirus pandemic on Tuesday, when more than 4,400 COVID-19 patients died, the most in a single day since the start of the outbreak, and experts said that with cases continuing to accelerate, the worst is still to come.
3:42 a.m. Jan. 11, 2021 - By Jaimy Lee
Moderna to develop vaccine candidates for seasonal flu, HIVShares of Moderna Inc. were up 1.3% in premarket trading on Monday after the company said it plans to launch new development programs using its mRNA technology that will focus on developing vaccines for seasonal flu, HIV, and the Nipah virus. This follows the success of its mRNA COVID-19 vaccine, which is one of two vaccines to be authorized so far in the U.S. CEO Moderna also said it plans to expand its respiratory syncytial virus to include older adults, and it plans to test different vaccine combinations that fight the flu, COVID-19, RSV, and human metapneumovirus. "The uniquely challenging year of 2020 for all of society proved to be an extraordinary proof-of-concept period for Moderna," CEO Stéphane Bancel said in a news release. As part of its corporate update, Moderna said it had about $5.2 billion in cash as of Dec. 31, compared to the $1.2 billion in cash it had at the same time a year ago, and it expects to generate at least $11.7 billion in revenue in 2021 for its COVID-19 vaccine based on advance purchase agreements. Moderna's stock has soared 489.1% over the last year, while the S&P 500 is up 19.7%.
1:54 p.m. Jan. 10, 2021 - By Andrew Keshner
What side effects, if any, can you expect from a COVID-19 vaccine shot? Doctors have advised the CDC to be transparent and forthcoming about any side effectsDoctors have advised the CDC to be transparent and forthcoming about any side effects.
11:18 a.m. Dec. 7, 2020 - By Quentin Fottrell
Biden wants Americans to wear masks for 100 days — do they protect against COVID-19 or merely promote healthy behavior? ‘Modeling suggests that near universal masking could prevent 180,000 COVID-19 deaths,’ one expert told MarketWatch‘Modeling suggests that near universal masking could prevent 180,000 COVID-19 deaths,’ one expert told MarketWatch.
7:46 a.m. Dec. 7, 2020 - By Andrew Keshner
Want your loved one in a nursing home to get a COVID-19 vaccine? Ask these questions first There are approximately 3 million people living in long-term care facilities, according to the CDCThere are approximately 3 million people living in long-term care facilities, according to the CDC.
2:18 a.m. Dec. 7, 2020 - By Quentin Fottrell
Joe Biden’s pandemic plan: Restore Obamacare, mandatory masks, paid sick leave and free COVID-19 tests The President-elect said: ‘Dealing with the coronavirus pandemic is one of the most important battles our administration will face’The President-elect said: ‘Dealing with the coronavirus pandemic is one of the most important battles our administration will face.’
10:12 a.m. Dec. 2, 2020 - By Quentin Fottrell
‘Cytokine Storm’ — the ‘intriguing’ similarity between COVID-19 and the 1918 influenza A hyperinflammatory immune response to the influenza of 1918 was seen as one reason healthy people were so hard hit. How big a role has it played in 2020?A hyperinflammatory immune response to the influenza of 1918 was seen as one reason healthy people were so hard hit. How big a role has it played in 2020?
3:01 a.m. Nov. 29, 2020 - By Andrew Keshner
Americans pay more for prescription drugs than anyone else. Can Amazon Pharmacy change that? What the e-commerce behemoth’s entry into the pharmacy business could mean for consumers’ health and wealthWhat the e-commerce behemoth’s entry into the pharmacy business could mean for consumers’ health and wealth
12:57 a.m. Nov. 26, 2020 - By Meera Jagannathan
The CDC says you shouldn’t travel for Thanksgiving — how to reduce risk of infection if you do ‘The safest way to celebrate Thanksgiving is to celebrate at home with the people you live with,’ the agency said ‘The safest way to celebrate Thanksgiving is to celebrate at home with the people you live with,’ the agency said.
10:55 a.m. Nov. 25, 2020 - By Ciara Linnane
Hospital workers called exhausted as U.S. records highest number of COVID deaths since May Parts of Europe are reporting declining cases and Sicily has asked Cuba to send doctors and nursesThe U.S. recorded the highest number of deaths from the coronavirus illness COVID-19 since May on Tuesday, and continues to average close to 200,000 new cases a day, with hospitals across the nation reporting exhausted health care workers and steadily filling intensive care units.
11:10 a.m. Nov. 24, 2020 - By Ciara Linnane
U.S. is ‘in the middle of the Fight of the Century,’ says former CDC head as cases rise in 45 states, hospitalizations set record U.S. has averaged 173,147 cases a day in the past week, and more than 85,000 COVID-19 patients are in a hospitalThe U.S. case tally from the coronavirus illness COVID-19 climbed above 12.84 million on Tuesday and hospitalizations again reached record levels, with 45 states reporting rising infections.
2:09 a.m. Nov. 23, 2020 - By Ciara Linnane
South Dakota emergency-room nurse says some patients insist COVID-19 isn’t real even as they’re dying from it ‘When they should be spending time FaceTime-ing their families, they’re just filled with anger and hatred. I just can’t believe those are their last words,’ says nurse Jodi DoeringA South Dakota nurse took to Twitter on Sunday to highlight a tragic feature of the coronavirus pandemic, patients who rail against health-care workers because they don’t believe that COVID-19 is real.
1:03 a.m. Nov. 17, 2020 - By Cecilia Clark
College students suspended for breaking COVID-19 rules—can you get a refund? Know your school’s COVID-19 policies and how they affect tuition money and financial aid if you don’t complyStudents returned this fall to rigid COVID-19 prevention rules. And noncompliance can be costly.
10:54 a.m. Nov. 9, 2020 - By Cody Willard
A new normal is on the horizon for investors — but what does that look like? Coronavirus treatments will be a game changer. But they won’t change the trajectory of innovative companies making their way through the world Coronavirus treatments will be a game changer. But they won’t change the trajectory of innovative companies making their way through the world.
2:42 a.m. Nov. 9, 2020 - By Jaimy Lee
To defeat COVID-19, ‘we need a unified national strategy,’ says public health expert Dr. Howard Koh Koh served as assistant secretary of health during the H1N1 flu pandemic in 2009Dr. Howard Koh knows what it’s like to be a government official running a pandemic response.
9:08 a.m. Nov. 3, 2020 - By Bruce Horovitz
Life will never be the same for people over 60 — even with a COVID-19 vaccine These are the likely long-term impacts on gatherings, travel, eating, medicine, home life and even public restroomsMost will keep taking precautions. Here’s a preview of post-vaccine life for older Americans.
Browse topics:

Filter results by

Location

Us (267)

Asia Pacific (47)

Europe (44)

China (38)

Eu (33)

Latin America (9)

Link to MarketWatch's Slice.